- Vasorin as an actor of bone turnover? Andrique C, Bonnet AL, Dang J, Lesieur J, Krautzberger AM, Baroukh B, Torrens C, Sadoine J, Schmitt A, Rochefort GY, Bardet C, Six I, Houillier P, Tharaux PL, Schrewe H, Gaucher C, Chaussain C. J Cell Physiol. 2024 Mar 19. doi: 10.1002/jcp.31257. Online ahead of print.PMID: 38504496
- Implantation of engineered human microvasculature to study human infectious diseases in mouse models .iScience. 2023. Feb 27;26(4):106286. PMID: 36942053
- Deep Paleoproteotyping and Microtomography Revealed No Heart Defect nor Traces of Embalming in the Cardiac Relics of Blessed Pauline Jaricot. J.Int J Mol Sci. 2023 Feb 3;24(3):3011. PMID: 36769339
- Prevalence of Enthesopathies in Adults With X-linked Hypophosphatemia: Analysis of Risk Factors.J Clin Endocrinol Metab. 2022. PMID: 34406383
- Dental pulp stem cells as a promising model to study imprinting diseases. Int J Oral Sci. 2022 Apr 2;14(1):19. doi: 10.1038/s41368-022-00169-1.
- Combining sclerostin neutralization with tissue engineering: An improved strategy for craniofacial bone repair. Acta Biomater. 2021 . PMID: 34875361
- Characteristics of Large Animal Models for Current Cell-Based Oral Tissue Regeneration. Tissue Eng Part B Rev. 2021. doi: 10.1089/ten.TEB.2020.0384.
- Acellular dense collagen-S53P4 bioactive glass hybrid gel scaffolds form more bone than stem cell delivered constructs. Mater Sci Eng C Mater Biol Appl. 2021 doi: 10.1016/j.msec.2020.111743.
- A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia. Sci Adv. 2021 doi: 10.1126/sciadv.abj5018.